OTC Labeling Final Rule Extension For ANDA Holders Requested By Perrigo
This article was originally published in The Tan Sheet
Executive Summary
FDA's draft guidance stating ANDA holders need not wait for OTC reference listed drug makers to implement "Drug Facts" labeling before they use such labeling would create an "unexpected hardship" on private labelers, Perrigo maintains in comments to the agency.